Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
NAD⁺ & NMN
Video summary

NMN in mice prone to pancreatic disease: what the 2019 study found

The description says a 2019 NMN study in genetically altered mice predisposed to pancreatic disease raised concerns in that specific model, but does not establish cancer risk or prove safety in healthy people. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The described 2019 experiment used NMN in genetically altered mice predisposed to pancreatic disease. [1]

  2. The description says the study raises concerns in that specific mouse model. [1]

  3. The creator says the findings do not establish cancer risk or prove safety in healthy people. [1]

The source at a glance

Study type / format
Video description summarizing a 2019 mouse study
Population / context
Genetically altered mice predisposed to pancreatic disease, as described; healthy people are mentioned only as a group the findings do not cover.
Summary based on
Creator description
Original publication
September 21, 2026

NMN study in mice predisposed to pancreatic disease

The description presents a 2019 study that asked whether boosting NAD+ promotes cancer. The experiment used NMN in genetically altered mice predisposed to pancreatic disease. The creator says the work raises concerns in that specific model. The description does not report how many mice were studied, the dose, the duration or the exact outcome measures.

Supporting source [1]

Pancreatic changes, inflammation and senescent-cell signaling

According to the description, researchers observed pancreatic changes in these mice. The video also covers NMN versus NAD+, inflammation and signaling from senescent cells. The description does not say whether these observations were harmful, how large they were, or whether they were compared with a control group.

Supporting source [1]

Mouse findings do not settle risk or safety in people

The creator states that the mouse results do not establish cancer risk, and do not prove safety, in healthy people. The description stresses the limits of applying mouse findings to humans. This is a description of a video; the video and transcript were not reviewed, so details of the study design and results cannot be checked here.

Supporting source [1]

How to interpret this

This is only the video description; the video and transcript were not reviewed. The description gives no sample size, dose, duration, control group or exact outcome measures, and mouse results cannot be transferred directly to humans.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

[1]
NAD+ and Cancer: What the NMN Mouse Study Actually Found

Derek Decoded · youtube.com · September 21, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    NMN in genetically altered mice predisposed
  2. Finding 2 ↑

    raises concerns in that specific model
  3. Finding 3 ↑

    does not establish cancer risk—or prove safety

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…